SPEX | tickerfilter.com

Fundamental analysis

49%

Profitability 60%

Dept financing 4%

Liquidity 6%

Performance 60%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

$1.63

P/E Ratio

N/A

DAY RANGE

$1.63 - $1.63

EPS

$0.00

52 WEEK RANGE

$0.65 - $5.52

52 WEEK CHANGE

-$54.08

MARKET CAP

7.866 M

YIELD

N/A

SHARES OUTSTANDING

4.826 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$20,056,683

AVERAGE 30 VOLUME

$7,617,176

Company detail

CEO: Anthony C. Hayes
Region: US
Website: http://www.spherix.com
Employees: 0
IPO year: -

Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Spherix, Inc. is a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency, as well as 2 U.S. patents in pharmaceutical technology. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.

SPEX - Spherix Incorporated